thiazoles has been researched along with lusutrombopag in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 14 (46.67) | 24.3611 |
| 2020's | 16 (53.33) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, ES | 1 |
| Ishibashi, T; Kano, T; Katsube, T; Wajima, T | 1 |
| Abe, S; Kamimura, K; Kawai, H; Sakamaki, A; Takamura, M; Terai, S; Tsuchiya, A; Watanabe, T; Yamagiwa, S | 1 |
| Ishimura, N; Isoda, K; Kataoka, M; Kinoshita, Y; Miyake, T; Sato, S; Tobita, H; Yazaki, T | 1 |
| Abe, K; Fujita, M; Hayashi, M; Ohira, H; Okai, K; Takahashi, A | 1 |
| Dohi, K; Gahara, Y; Hasegawa, M; Kitaura, M; Kurino-Yamada, T; Kuwabara, K; Nogami, W; Oshima, I; Sugiyama, K; Takahashi, K; Yamada, H; Yoshida, H | 1 |
| Fukuhara, T; Imawari, M; Izumi, N; Kano, T; Katsube, T; Kawazoe, S; Kudo, M; Kurokawa, M; Ochiai, T; Osaki, Y; Seike, M; Tamai, H; Tanaka, K; Tateishi, R; Yamamoto, K | 1 |
| Katano, T; Mizuta, K; Okada, N; Sanada, Y | 1 |
| Abiru, S; Fukuhara, T; Hidaka, H; Igura, T; Imawari, M; Ishikawa, T; Izumi, N; Kano, T; Katsube, T; Kimura, K; Kudo, M; Kurokawa, M; Kurosaki, M; Nagata, T; Ochiai, T; Osaki, Y; Seike, M; Tanaka, H; Tanaka, K; Yamamoto, K | 1 |
| Enomoto, N; Higuchi, M; Itakura, J; Izumi, N; Komiyama, Y; Kubota, Y; Kurosaki, M; Nakanishi, H; Okada, M; Shimizu, T; Takada, H; Takahashi, Y; Takaura, K; Tamaki, N; Tsuchiya, K; Wang, W; Watakabe, K; Yasui, Y | 1 |
| Fukuhara, T; Kano, T; Katsube, T; Shimizu, R; Wajima, T | 1 |
| Al-Horani, RA; Clemons Bankston, P | 1 |
| Fukuhara, T; Kano, T; Katsube, T; Wajima, T | 1 |
| Hussar, DA | 1 |
| Akahane, T; Fujinaga, Y; Ishida, K; Kaji, K; Kawaratani, H; Kaya, D; Kubo, T; Moriya, K; Namisaki, T; Sawada, Y; Shimozato, N; Takaya, H; Tsuji, Y; Yoshiji, H | 1 |
| Alkhouri, N; Bentley, R; Imawari, M; Izumi, N; Kano, T; Ochiai, T; Osaki, Y; Trevisani, F | 1 |
| Flamm, SL; Nilles, KM | 1 |
| Arase, Y; Atsukawa, M; Hidaka, H; Horie, R; Itokawa, N; Iwakiri, K; Iwasaki, S; Kagawa, T; Kako, M; Koizumi, W; Miyazaki, K; Okina, S; Satoh, T; Shao, X; Suzuki, T; Takiguchi, H; Uojima, H; Wada, N | 1 |
| Asama, H; Fukushima, T; Kawano, K; Kobayashi, S; Maeda, S; Morimoto, M; Nagashima, S; Ohkawa, S; Sano, Y; Tanaka, S; Ueno, M | 1 |
| Al, M; Armstrong, N; Buksnys, T; Büyükkaramikli, N; Drachen, T; Duffy, S; Huertas Carrera, V; Kleijnen, J; Penton, H; Raatz, H; Riemsma, R; Ryder, S; Shah, D; Swift, S; Wetzelaer, P; Worthy, G | 1 |
| Kanazu, T; Katsube, T; Kawachi, T; Ninomiya, M; Wajima, T | 1 |
| Isoda, N; Koyashiki, Y; Kurata, H; Maeda, H; Miura, K; Morimoto, N; Nomoto, H; Numao, N; Sasaki, T; Takaoka, Y; Watanabe, S; Yamamoto, H | 1 |
| Ishibashi, K; Kaneko, T; Takano, Y | 1 |
| Afdhal, N; Bentley, R; Giannini, EG; Kano, T; Ochiai, T; Shrestha, P | 1 |
| Katsube, T; Shimizu, R; Wajima, T | 1 |
| Buscarini, E; Dinis-Ribeiro, M; Fuccio, L; Hassan, C; Radaelli, F | 1 |
| Bubalo, J; Gilreath, J; Lo, M | 1 |
| Fujiwara, M; Hiroi, S; Hongo, Y; Igarashi, A; Iwasaki, K; Kitanishi, Y; Takeshima, T; Tateishi, R; Yoshida, M | 1 |
| Arai, T; Arase, Y; Atsukawa, M; Furuichi, Y; Hidaka, H; Itoi, T; Kako, M; Takeuchi, H; Uojima, H | 1 |
| Biolato, M; Grieco, A; Marrone, G; Miele, L; Vitale, F | 1 |
5 review(s) available for thiazoles and lusutrombopag
| Article | Year |
|---|---|
New Small Molecule Drugs for Thrombocytopenia: Chemical, Pharmacological, and Therapeutic Use Considerations.
Topics: Aminopyridines; Animals; Cinnamates; Drug Development; Humans; Morpholines; Oxazines; Pyridines; Pyrimidines; Receptors, Thrombopoietin; Small Molecule Libraries; Syk Kinase; Thiazoles; Thiophenes; Thrombocytopenia | 2019 |
Lusutrombopag Is Safe and Efficacious for Treatment of Thrombocytopenia in Patients With and Without Hepatocellular Carcinoma.
Topics: Carcinoma, Hepatocellular; Cinnamates; Humans; Liver Neoplasms; Thiazoles; Thrombocytopenia | 2020 |
Thrombocytopenia in Chronic Liver Disease: New Management Strategies.
Topics: Chronic Disease; Cinnamates; Hemorrhage; Humans; Liver Diseases; Platelet Count; Platelet Transfusion; Receptors, Thrombopoietin; Risk Factors; Surgical Procedures, Operative; Thiazoles; Thiophenes; Thrombocytopenia; Thrombopoiesis | 2020 |
Avatrombopag and lusutrombopag for thrombocytopenia in people with chronic liver disease needing an elective procedure: a systematic review and cost-effectiveness analysis.
Topics: Bayes Theorem; Cinnamates; Clinical Trials as Topic; Cost-Benefit Analysis; End Stage Liver Disease; Humans; Models, Economic; Platelet Transfusion; Quality-Adjusted Life Years; Receptors, Thrombopoietin; Secondary Care; Technology Assessment, Biomedical; Thiazoles; Thiophenes; Thrombocytopenia | 2020 |
Thrombopoietin Receptor Agonists (TPO-RAs): Drug Class Considerations for Pharmacists.
Topics: Benzoates; Cinnamates; Dose-Response Relationship, Drug; Drug Monitoring; Health Knowledge, Attitudes, Practice; Humans; Hydrazines; Pharmacists; Platelet Count; Pyrazoles; Receptors, Fc; Receptors, Thrombopoietin; Recombinant Fusion Proteins; Thiazoles; Thiophenes; Thrombocytopenia; Thrombopoietin | 2021 |
6 trial(s) available for thiazoles and lusutrombopag
| Article | Year |
|---|---|
Population Pharmacokinetic and Pharmacodynamic Modeling of Lusutrombopag, a Newly Developed Oral Thrombopoietin Receptor Agonist, in Healthy Subjects.
Topics: Adult; Age Factors; Area Under Curve; Body Weight; Cinnamates; Dose-Response Relationship, Drug; Double-Blind Method; Female; Healthy Volunteers; Humans; Male; Middle Aged; Models, Biological; Racial Groups; Receptors, Thrombopoietin; Sex Factors; Thiazoles; White People | 2016 |
A randomized controlled trial of lusutrombopag in Japanese patients with chronic liver disease undergoing radiofrequency ablation.
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Chronic Disease; Cinnamates; Double-Blind Method; Female; Half-Life; Humans; Japan; Liver Diseases; Liver Neoplasms; Male; Middle Aged; Platelet Count; Platelet Transfusion; Preoperative Care; Radiofrequency Ablation; Receptors, Thrombopoietin; Thiazoles; Thrombocytopenia; Thrombosis | 2019 |
Lusutrombopag Reduces Need for Platelet Transfusion in Patients With Thrombocytopenia Undergoing Invasive Procedures.
Topics: Aged; Catheter Ablation; Cinnamates; Double-Blind Method; Female; Follow-Up Studies; Humans; Incidence; Japan; Liver Cirrhosis; Male; Platelet Transfusion; Postoperative Hemorrhage; Retrospective Studies; Thiazoles; Thrombocytopenia; Treatment Outcome | 2019 |
Effects of Food and Calcium Carbonate on the Pharmacokinetics of Lusutrombopag, a Novel Thrombopoietin Receptor Agonist.
Topics: Administration, Oral; Adult; Aged; Biological Availability; Calcium Carbonate; Cinnamates; Cross-Over Studies; Fasting; Female; Food-Drug Interactions; Healthy Volunteers; Humans; Male; Middle Aged; Receptors, Thrombopoietin; Tablets; Thiazoles; Young Adult | 2019 |
Effectiveness of Lusutrombopag in Patients with Mild to Moderate Thrombocytopenia.
Topics: Aged; Cinnamates; Female; Humans; Male; Platelet Count; Postoperative Complications; Receptors, Thrombopoietin; Thiazoles; Thrombocytopenia; Time Factors; Treatment Outcome | 2020 |
Impact of Anti-GPIIb/IIIa Antibody-Producing B Cells as a Predictor of the Response to Lusutrombopag in Thrombocytopenic Patients with Liver Disease.
Topics: Aged; Aged, 80 and over; Autoantibodies; B-Lymphocytes; Blood Platelets; Cinnamates; Female; Humans; Liver Diseases; Male; Middle Aged; Multivariate Analysis; Organ Size; Platelet Count; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Spleen; Thiazoles; Thrombocytopenia | 2021 |
19 other study(ies) available for thiazoles and lusutrombopag
| Article | Year |
|---|---|
Lusutrombopag: First Global Approval.
Topics: Cinnamates; Drug Approval; Humans; Japan; Liver Diseases; Receptors, Thrombopoietin; Thiazoles; Thrombocytopenia | 2016 |
Lusutrombopag increases hematocytes in a compensated liver cirrhosis patient.
Topics: Carcinoma, Hepatocellular; Cinnamates; Hepatitis C; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Thiazoles; Thrombocytopenia | 2017 |
Efficacy of Repeated Lusutrombopag Administration for Thrombocytopenia in a Patient Scheduled for Invasive Hepatocellular Carcinoma Treatment.
Topics: Carcinoma, Hepatocellular; Chronic Disease; Cinnamates; Female; Humans; Liver Diseases; Liver Neoplasms; Middle Aged; Platelet Count; Thiazoles; Thrombocytopenia | 2017 |
Two cases of liver cirrhosis treated with lusutrombopag before partial splenic embolization.
Topics: Adult; Cinnamates; Embolization, Therapeutic; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Thiazoles | 2017 |
Development of a new knock-in mouse model and evaluation of pharmacological activities of lusutrombopag, a novel, nonpeptidyl small-molecule agonist of the human thrombopoietin receptor c-Mpl.
Topics: Animals; Blood Platelets; Cell Line; Cell Proliferation; Cinnamates; Drug Evaluation, Preclinical; Gene Knock-In Techniques; Humans; Megakaryocytes; Mice; Mice, Transgenic; Models, Biological; Receptors, Thrombopoietin; Thiazoles | 2018 |
Lusutrombopag as pretreatment for liver biopsy following liver transplantation.
Topics: Adolescent; Biopsy; Cinnamates; Humans; Liver; Liver Transplantation; Living Donors; Male; Platelet Count; Preoperative Care; Receptors, Thrombopoietin; Thiazoles; Thrombocytopenia | 2018 |
Real-life experience of lusutrombopag for cirrhotic patients with low platelet counts being prepared for invasive procedures.
Topics: Aged; Carcinoma, Hepatocellular; Catheter Ablation; Chemoembolization, Therapeutic; Cinnamates; Esophageal and Gastric Varices; Female; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Platelet Count; Platelet Transfusion; Receptors, Thrombopoietin; Retrospective Studies; Sclerotherapy; Thiazoles; Thrombocytopenia | 2019 |
Pharmacokinetic/Pharmacodynamic Modelling and Simulation of Lusutrombopag, a Novel Thrombopoietin Receptor Agonist, for the Treatment of Thrombocytopenia in Patients with Chronic Liver Disease Undergoing Invasive Procedures.
Topics: Adult; Aged; Aged, 80 and over; Blood Platelets; Chronic Disease; Cinnamates; Female; Humans; Liver Diseases; Male; Middle Aged; Models, Biological; Platelet Count; Receptors, Thrombopoietin; Thiazoles; Thrombocytopenia; Young Adult | 2019 |
New Drugs 2019, part 4.
Topics: Aminopyridines; Cinnamates; Drug Approval; Factor Xa; Humans; Macrolides; Morpholines; Oligonucleotides; Oxazines; Pyridines; Pyrimidines; Recombinant Proteins; RNA, Small Interfering; Sisomicin; Tetracyclines; Thiazoles; Thiophenes; United States; United States Food and Drug Administration | 2019 |
Repeated Lusutrombopag Treatment for Thrombocytopenia in Patients with Chronic Liver Disease.
Topics: Chronic Disease; Cinnamates; Humans; Liver Diseases; Receptors, Thrombopoietin; Retrospective Studies; Thiazoles; Thrombocytopenia | 2021 |
Human mass balance, metabolism, and cytochrome P450 phenotyping of lusutrombopag.
Topics: Administration, Oral; Cinnamates; Cytochrome P-450 Enzyme System; Feces; Humans; Male; Oxidation-Reduction; Thiazoles | 2021 |
Lusutrombopag is effective and safe in patients with chronic liver disease and severe thrombocytopenia: a multicenter retrospective study.
Topics: Cinnamates; Humans; Liver Diseases; Receptors, Thrombopoietin; Retrospective Studies; Thiazoles; Thrombocytopenia | 2020 |
Lusutrombopag as a substitute for platelet transfusion for thrombocytopenia associated with chronic liver disease in a patient undergoing endoscopic spinal surgery: A case report.
Topics: Aged; Blood Loss, Surgical; Cinnamates; End Stage Liver Disease; Endoscopy; Female; Humans; Lumbar Vertebrae; Spinal Fractures; Thiazoles; Thrombocytopenia | 2021 |
Bleeding events in lusutrombopag-treated thrombocytopenic patients.
Topics: Aged; Biopsy; Blood Loss, Surgical; Chemoembolization, Therapeutic; Chronic Disease; Cinnamates; Endoscopy, Digestive System; Female; Humans; Liver Diseases; Male; Middle Aged; Perioperative Care; Platelet Transfusion; Postoperative Hemorrhage; Radiofrequency Ablation; Randomized Controlled Trials as Topic; Receptors, Thrombopoietin; Retrospective Studies; Thiazoles; Thrombocytopenia; Tooth Extraction | 2021 |
Quantitative systems pharmacology model of thrombopoiesis and platelet life-cycle, and its application to thrombocytopenia based on chronic liver disease.
Topics: Blood Platelets; Cinnamates; Computer Simulation; End Stage Liver Disease; Humans; Receptors, Thrombopoietin; Thiazoles; Thrombopoiesis | 2021 |
Second-generation thrombopoietin receptor agonists: New players in the management of cirrhotic patients undergoing therapeutic endoscopy?
Topics: Cinnamates; Endoscopy; Humans; Liver Cirrhosis; Receptors, Thrombopoietin; Surveys and Questionnaires; Thiazoles; Thiophenes; Thrombocytopenia | 2021 |
Effects of Lusutrombopag on Post-invasive Procedural Bleeding in Thrombocytopenic Patients with Chronic Liver Disease.
Topics: Adolescent; Chronic Disease; Cinnamates; Humans; Liver Diseases; Receptors, Thrombopoietin; Thiazoles | 2022 |
Lusutrombopag has slightly stronger effects on patients with mild thrombocytopenia compared with those with severe thrombocytopenia: A multicenter propensity score matching study.
Topics: Cinnamates; Humans; Propensity Score; Receptors, Thrombopoietin; Thiazoles; Thrombocytopenia | 2022 |
A single course of lusutrombopag for multiple invasive procedures in cirrhosis-associated thrombocytopenia: A case series.
Topics: Cinnamates; Humans; Liver Cirrhosis; Thiazoles; Thrombocytopenia | 2022 |